⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult malignant fibrous histiocytoma

Every month we try and update this database with for adult malignant fibrous histiocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaNCT00002764
Endometrial Can...
Kidney Cancer
Metastatic Canc...
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
conventional su...
16 Years - European Organisation for Research and Treatment of Cancer - EORTC
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaNCT00064220
Sarcoma
soblidotin
15 Years - Daiichi Sankyo
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaNCT00006357
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
imatinib mesyla...
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or PelvisNCT00091351
Sarcoma
conventional su...
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaNCT00053794
Endometrial Can...
Sarcoma
perifosine
18 Years - 120 YearsCanadian Cancer Trials Group
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaNCT00085475
Sarcoma
imatinib mesyla...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00041249
Gastrointestina...
Sarcoma
brostallicin
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryNCT00450736
Childhood Malig...
Sarcoma
celecoxib
adjuvant therap...
radiation thera...
18 Years - 120 YearsUniversity of Miami
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaNCT00002641
Endometrial Can...
Kidney Cancer
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
isolated perfus...
adjuvant therap...
conventional su...
radiation thera...
16 Years - 69 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue SarcomaNCT00423618
Sarcoma
radiotherapy
16 Years - 120 YearsSheffield Teaching Hospitals NHS Foundation Trust
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue SarcomaNCT00740597
Sarcoma
gene expression...
polymerase chai...
western blottin...
neoadjuvant the...
therapeutic con...
intensity-modul...
18 Years - City of Hope Medical Center
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaNCT00410462
Ovarian Cancer
Sarcoma
Small Intestine...
brostallicin
doxorubicin hyd...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaNCT00030784
Sarcoma
ifosfamide
pegylated lipos...
18 Years - 70 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue SarcomaNCT01189253
Sarcoma
doxorubicin hyd...
trabectedin
laboratory biom...
quality-of-life...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00061984
Sarcoma
pegfilgrastim
doxorubicin hyd...
ifosfamide
multimodality t...
18 Years - 60 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaNCT00002764
Endometrial Can...
Kidney Cancer
Metastatic Canc...
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
conventional su...
16 Years - European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue SarcomaNCT00003052
Sarcoma
doxorubicin hyd...
etoposide
ifosfamide
conventional su...
hyperthermia tr...
radiation thera...
18 Years - 70 YearsNational Cancer Institute (NCI)
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaNCT00085475
Sarcoma
imatinib mesyla...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00041249
Gastrointestina...
Sarcoma
brostallicin
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryNCT00450736
Childhood Malig...
Sarcoma
celecoxib
adjuvant therap...
radiation thera...
18 Years - 120 YearsUniversity of Miami
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaNCT00245102
Adult Angiosarc...
Adult Epithelio...
Adult Leiomyosa...
Adult Malignant...
Adult Neurofibr...
Adult Synovial ...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
Uterine Carcino...
Uterine Leiomyo...
sorafenib tosyl...
18 Years - National Cancer Institute (NCI)
Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEXNCT00900211
Sarcoma
microarray anal...
molecular diagn...
biologic sample...
16 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: